Stewards of Stem Cell and Kidney Transplantation: The Critical Role of Pharmacists in Staving Off CMV Infection

Faculty

Genovefa Papanicolaou, MD, FIDSA, FASTCT
Attending Physician, Infectious Disease Service
Memorial Sloan Kettering Cancer Center 
Professor, Weill Cornell Medical College, Cornell University 
New York, NY
Andrew Lin, PharmD, BCOP
Manager Clinical Pharmacy Practice, BMT & Cellular Therapy Services
Memorial Sloan Kettering Cancer Center
New York, NY

Statement of Need

Cytomegalovirus (CMV) is a condition with high seroprevalence in the U.S. population and remains a primary concern in solid organ transplants, particularly allogeneic hematopoietic stem cell transplants (HSCTs) and kidney transplants. Pharmacists are an integral part of the team-based care of patients following these transplants and are positioned to improve patient outcomes; however, they are not consistently included in patient care. To better contribute to CMV management strategies, pharmacists must understand the prevalence and impact of CMV in this patient population for early surveillance and patient assistance programs in hospital settings and must differentiate traditional and novel approaches to prophylaxis.

In this CME Outfitters Snack activity, expert faculty will discuss clinical experience, current and late-breaking study information, and how to integrate data into everyday clinical workflows to improve management of patients receiving HSCTs or kidney transplants.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Discuss the role of the pharmacist in managing CMV associated with hematopoietic stem cell transplantation and kidney transplantation

Financial Support

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Target Audience

Non-retail pharmacists

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacists (ACPE) 0.5

This application-based activity is approved for 0.50 contact hours (0.05 CEUs) of continuing pharmacy credit (JA0007185-0000-24-043-H01-P).

Disclosure Declaration

Dr. Papanicolaou reports the following financial relationships:

Consultant: Armata Pharmaceuticals, Inc.; Genentech, Inc.; MSD; SymBio Pharmaceuticals; Takeda Pharmaceuticals U.S.A., Inc.; Trellis Bioscience, Inc.

Research Support: MSD (paid to institution)

Dr. Lin reports the following financial relationships:

Advisory Board: Sanofi

The following individuals have no financial relationships to disclose: 

Rebecca Vargas-Jackson, MD  (Peer Reviewer)
Joshua Caballero, PharmD, BCPP, FCCP (Peer Reviewer)
Susan Perry (Planning Committee)
Warren Beckman (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

SN-238-070124-44

Stewards of Stem Cell and Kidney Transplantation: The Critical Role of Pharmacists in Staving Off CMV Infection
Event Date: 07/01/2024